Study to Observe Safety and Efficacy of Nexavar in Treatment of Kidney Cancer
Status:
Withdrawn
Trial end date:
2018-04-01
Target enrollment:
Participant gender:
Summary
The objective of this Non-Interventional study is to evaluate the effectiveness & safety of
Nexavar in advanced Renal Cell Carcinoma (RCC) patients under daily-life treatment conditions
based on age of the patient (older (age >70 years) and younger patients (age <70 years).
Specifically investigated are the tumor status, duration of Nexavar ® treatment (number of
cycles) and incidence of Hand foot Skin Reaction.